These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38446042)

  • 1. Development and Validation of a Deep Learning Model to Reduce the Interference of Rectal Artifacts in MRI-based Prostate Cancer Diagnosis.
    Hu L; Guo X; Zhou D; Wang Z; Dai L; Li L; Li Y; Zhang T; Long H; Yu C; Shi ZW; Han C; Lu C; Zhao J; Li Y; Zha Y; Liu Z
    Radiol Artif Intell; 2024 Mar; 6(2):e230362. PubMed ID: 38446042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting Prostate Cancer Classification From Rectal Artifacts via Targeted Adversarial Training.
    Hu L; Zhou D; Xu J; Lu C; Han C; Shi Z; Zhu Q; Gao X; Wang N; Liu Z
    IEEE J Biomed Health Inform; 2024 Jul; 28(7):3997-4009. PubMed ID: 38954559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated deep-learning system in the assessment of MRI-visible prostate cancer: comparison of advanced zoomed diffusion-weighted imaging and conventional technique.
    Hu L; Fu C; Song X; Grimm R; von Busch H; Benkert T; Kamen A; Lou B; Huisman H; Tong A; Penzkofer T; Choi MH; Shabunin I; Winkel D; Xing P; Szolar D; Coakley F; Shea S; Szurowska E; Guo JY; Li L; Li YH; Zhao JG
    Cancer Imaging; 2023 Jan; 23(1):6. PubMed ID: 36647150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
    Singh S; Rogers H; Kanber B; Clemente J; Pye H; Johnston EW; Parry T; Grey A; Dinneen E; Shaw G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Giganti F; Atkinson D; Moore CM; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
    Radiology; 2022 Dec; 305(3):623-630. PubMed ID: 35916679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of machine learning models based on biparametric MRI for diagnosis of prostate cancer and clinically significant prostate cancer].
    Qiao XM; Hu CH; Hu S; Hu CH; Wang XM; Shen JK; Ji LB; Song Y; Bao J
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1446-1454. PubMed ID: 37198106
    [No Abstract]   [Full Text] [Related]  

  • 6. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
    Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
    Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI.
    Sun Z; Wu P; Cui Y; Liu X; Wang K; Gao G; Wang H; Zhang X; Wang X
    J Magn Reson Imaging; 2023 Oct; 58(4):1067-1081. PubMed ID: 36825823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a validated prostate MRI deep learning system to independent same-vendor multi-institutional data: demonstration of transferability.
    Netzer N; Eith C; Bethge O; Hielscher T; Schwab C; Stenzinger A; Gnirs R; Schlemmer HP; Maier-Hein KH; Schimmöller L; Bonekamp D
    Eur Radiol; 2023 Nov; 33(11):7463-7476. PubMed ID: 37507610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study.
    Zhao L; Bao J; Qiao X; Jin P; Ji Y; Li Z; Zhang J; Su Y; Ji L; Shen J; Zhang Y; Niu L; Xie W; Hu C; Shen H; Wang X; Liu J; Tian J
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):727-741. PubMed ID: 36409317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal Cancer at MRI.
    Xia W; Li D; He W; Pickhardt PJ; Jian J; Zhang R; Zhang J; Song R; Tong T; Yang X; Gao X; Cui Y
    Radiol Artif Intell; 2024 Mar; 6(2):e230152. PubMed ID: 38353633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Hamm CA; Baumgärtner GL; Biessmann F; Beetz NL; Hartenstein A; Savic LJ; Froböse K; Dräger F; Schallenberg S; Rudolph M; Baur ADJ; Hamm B; Haas M; Hofbauer S; Cash H; Penzkofer T
    Radiology; 2023 May; 307(4):e222276. PubMed ID: 37039688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
    Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
    J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer.
    Montoya Perez I; Merisaari H; Jambor I; Ettala O; Taimen P; Knaapila J; Kekki H; Khan FL; Syrjälä E; Steiner A; Syvänen KT; Verho J; Seppänen M; Rannikko A; Riikonen J; Mirtti T; Lamminen T; Saunavaara J; Falagario U; Martini A; Pahikkala T; Pettersson K; Boström PJ; Aronen HJ
    J Magn Reson Imaging; 2022 Feb; 55(2):465-477. PubMed ID: 34227169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biparametric Magnetic Resonance Imaging-Derived Nomogram to Detect Clinically Significant Prostate Cancer by Targeted Biopsy for Index Lesion.
    Kim MJ; Park SY
    J Magn Reson Imaging; 2022 Apr; 55(4):1226-1233. PubMed ID: 34296803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators.
    Patel HD; Koehne EL; Shea SM; Fang AM; Gerena M; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Rais-Bahrami S; Gupta GN
    BJU Int; 2023 Feb; 131(2):227-235. PubMed ID: 35733400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Artificial Intelligence-Aided Diagnosis System for Clinically Significant Prostate Cancer with MRI: A Diagnostic Comparison Study.
    Jiang KW; Song Y; Hou Y; Zhi R; Zhang J; Bao ML; Li H; Yan X; Xi W; Zhang CX; Yao YF; Yang G; Zhang YD
    J Magn Reson Imaging; 2023 May; 57(5):1352-1364. PubMed ID: 36222324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
    Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
    J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Learning-Based Multiparametric MRI Model for Preoperative T-Stage in Rectal Cancer.
    Wei Y; Wang H; Chen Z; Zhu Y; Li Y; Lu B; Pan K; Wen C; Cao G; He Y; Zhou J; Pan Z; Wang M
    J Magn Reson Imaging; 2024 Mar; 59(3):1083-1092. PubMed ID: 37367938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.
    Bashkanov O; Rak M; Meyer A; Engelage L; Lumiani A; Muschter R; Hansen C
    Comput Methods Programs Biomed; 2023 Sep; 239():107624. PubMed ID: 37271051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.
    Zhang J; Kang F; Gao J; Jiao J; Quan Z; Ma S; Li Y; Guo S; Li Z; Jing Y; Zhang K; Yang F; Han D; Wen W; Zhang J; Ren J; Wang J; Guo H; Qin W
    J Nucl Med; 2023 Nov; 64(11):1750-1757. PubMed ID: 37652543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.